Dr. Reddy's to Acquire Haleon's Nicotinell Global NRT Portfolio (Outside the United States)
June 26, 2024
Dr. Reddy’s Laboratories SA has signed a definitive agreement to purchase Haleon’s Haleon group company Northstar Switzerland SARL to acquire Haleon’s global Nicotinell nicotine replacement therapy (NRT) brand portfolio outside the United States. The deal includes Nicotinell plus local leading brand names (Nicabate, Habitrol, Thrive) and applicable pipeline products, with about GBP 217 million revenue reported for the portfolio in CY23.
- Buyers
- Dr. Reddy's Laboratories SA, Dr. Reddy's Laboratories Ltd.
- Targets
- Northstar Switzerland SARL
- Sellers
- Haleon plc
- Industry
- Healthcare Services
- Location
- Switzerland
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Dr. Reddy's Laboratories to Acquire Nimbus Health GmbH
February 22, 2022
Healthcare Services
Dr. Reddy's Laboratories has entered into a definitive agreement to acquire German medical cannabis pioneer Nimbus Health GmbH. The acquisition will be completed for an upfront payment plus performance and milestone-based earn-outs, with Nimbus Health operating as a wholly owned subsidiary of Dr. Reddy's under its existing brand.
-
British American Tobacco (Modoral Brands) Acquires DRYFT Sciences' Nicotine Pouch Product Assets
November 16, 2020
Consumer Products
British American Tobacco’s U.S. business (through Modoral Brands Inc. / Reynolds American Inc.) acquired the nicotine pouch product assets of DRYFT Sciences, LLC. The deal transfers DRYFT’s all‑white nicotine pouch formulations and SKUs into BAT’s Velo product line to accelerate distribution and marketing reach in the modern oral nicotine segment.
-
Suave Brands Company (Yellow Wood) Acquires ChapStick from Haleon
January 25, 2024
Consumer Products
Suave Brands Company, a Yellow Wood Partners portfolio company, has acquired the ChapStick brand from Haleon. The transaction closed in the first half of 2024 and results in Haleon becoming a shareholder in Suave Brands Company as the buyers integrate ChapStick into the Suave platform to drive marketing, sales and operational synergies.
-
Pfizer Demerger of Consumer Healthcare JV; Haleon to Be Listed (Pfizer Exits 32% Stake)
June 1, 2022
Healthcare Services
Pfizer announced an update on its ownership interest in Haleon plc, the newly independent consumer healthcare company formed from the joint venture between Pfizer and GSK. Following the demerger and planned listings (LSE expected in July 2022, with ADSs on the NYSE), Pfizer will hold a 32% stake but intends to exit that interest in a disciplined manner to maximize value for Pfizer shareholders.
-
THL Partners Acquires Majority Stake in Red Nucleus from The Riverside Company
October 17, 2024
Healthcare Services
THL Partners (Thomas H. Lee Partners) has made a majority investment in Red Nucleus, a Yardley, Pennsylvania-based provider of medical communications, market access, learning & development, and R&D support for the life sciences industry. The Riverside Company sold its investment in Red Nucleus; the deal closed October 17, 2024 and will support expansion of Red Nucleus’ commercialization services under new CEO Mike Menta and continued involvement from founder Ian Kelly.
-
Altria Completes Acquisition of NJOY Holdings for About $2.75 Billion
June 1, 2023
Healthcare Services
Altria Group has completed its acquisition of NJOY Holdings for approximately $2.75 billion in cash, with up to an additional $500 million in contingent payments tied to FDA regulatory outcomes for certain NJOY products. The transaction expands Altria’s smoke-free portfolio and supports commercialization of NJOY ACE through Altria’s U.S. distribution network.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.